have used another radio-isotope (phosphorus 32) for the same purpose. The P-rays emitted by phosphorus 32 have a maximum range in tissue of about 7 mm., which means that a concentration of the isotope lying at a depth greater than this would go undetected. The authors point out that by using this isotope the effects of the active material lying at a greater depth or circulating in the blood are thereby obviated and this should result in a clearer picture being obtained. The disadvantage of this method lies in the fact that lesions in the posterior part of the eye were only made reasonably accessible to observation by rotation and fixation of the eye. These disadvantages are obviated by the use of di-iodofluorescein incorporating radio-active iodine 131 and emitting y rays which can be detected after they have passed through several centimetres of tissue.
Technique
To avoid radiation hazard it was thought advisable to use an amount of dye containing not more than 1 mc. radio-iodine for each patient. The dye, in approximately 2 ml. solution, was injected intravenously, and, following the practice of other workers, counting* was begun from 2 to 4 hours after injection. The counter tube (type G.M. 4) was shielded laterally by 1 cm. lead to absorb radiation from other parts of the body as far as possible. The aperture of this lead shield was 2.5 cm. 
RADIO-ACTIVE DI-IODOFLUORESCEIN
In all cases the count rates were quite low, in some cases so low as to be almost beyond the range of the instrument; and the authors feel that too much reliance should not be placed on any asymmetry between the count rates over each eye, quite apart from the possible physiological significance of such differences. Unfortunately a scintillation counter was not available at the time when these experiments were performed.
Clinical Results
Eight cases of malignant melanomatp, and one of retinoblastoma were investigated. One further case of each (Cases 6 and 11) was also tested, but the diagnosis was too uncertain to justify removal of the eye, and the subsequent absence of growth of the tumour in each case has confirmed their non-malignant nature; they are, however, included in the eye, but over an area between the right auditory meatus and the right outer canthus the count rate was some 50 per cent. greater than over the left side. In only one of this small series of eleven cases (Case 2) was there a significant asymmetry in the counts, and unfortunately these readings were near the limits of sensitivity of the instrument. In one other case (Case 4) the increased uptake was observed not over the tumour itself but posterior to it, and in another (Case 9) slightly higher readings were found over the unaffected eye.
It is interesting to note that the qount rate over the thyroid gland.did not greatly exceed that over the thigh, which shows that the iodine incorporated in the dye is not in a form which is readily taken up by the gland. This seems to indicate that the test should involve little radiation hazard to the thyroid, because of selective iodine concentration.
Retinoblastoma.-This single case can give little indication as to the possible use of radio-active testing as a diagnostic measure, but the practical difficulties of intravenous injection and exact application of the counter to a small and struggling infant hardly encourage the use of this method if further results are as negative as that recorded here.
As a final discouragement against its routine use in diagnosis it may be added that there is an inevitable difficulty in obtaining adequate doses of the radio-active drug to coincide with the discovery of such rare intra-ocular tumours, since neither can wait for the other-the di-iodofluorescein losing its potency, and the tumour progressing.
Summary
The selective uptake of the radio-active dye by the melanoma is very small or negligible as compared with that in the rest of the body, and the authors do not feel that this technique can be recommended as a routine diagnostic procedure. 
